)
BiomX (PHGE) investor relations material
BiomX Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Transitioned from a clinical-stage biopharmaceutical company to a diversified defense, security, and critical infrastructure technology portfolio in late 2025 and 2026.
Operations now focus on three subsidiaries: DFSL (LADAR-based detection), Zorronet (AI-powered security), and X Security (defense and first-response tech).
Recent acquisitions include 100% of Zorronet and 60% of DFSL, with strategic advisory from a former Mossad deputy head.
Discontinued legacy phage therapy programs and dissolved former Israeli subsidiary due to insolvency.
Financial performance and metrics
Audit opinion for FY2025 included a going concern qualification due to recurring losses and capital deficiency.
As of December 31, 2025, reported a stockholders' deficit of $(1,302,000) and continued net losses.
Zorronet and DFSL financials also raise substantial doubt about their ability to continue as going concerns.
Use of proceeds and capital allocation
Will not receive proceeds from resale of shares by selling stockholders; proceeds from warrant exercises, if any, will be used for general corporate purposes.
Assumed contingent earnout and bonus payment obligations tied to acquired subsidiaries' future performance.
- No auditor appointed for 2026; voting matters for the annual meeting remain unchanged.PHGE
Proxy filing22 Jun 2026 - Integrated AI and LADAR solutions drive growth in defense and security markets.PHGE
Investor presentation21 Jun 2026 - Vote on director election, equity plan amendment, and adjournment; board recommends approval.PHGE
Proxy filing8 Jun 2026 - Q1 2026 net loss was $19.1M amid a strategic pivot to defense and security tech.PHGE
Q1 202620 May 2026 - Vote sought on a new equity plan with evergreen increases and recent leadership changes disclosed.PHGE
Proxy filing25 Mar 2026 - Approval granted for issuance of shares tied to Series Y preferred stock and warrants.PHGE
EGM 202611 Mar 2026 - Meeting adjourned and rescheduled due to lack of quorum; voting instructions remain valid.PHGE
EGM 202625 Feb 2026 - 2025 net loss reached $36.2M; cash burn and insolvency drive urgent need for new financing.PHGE
Q4 202519 Feb 2026 - Approval sought for major share issuance and potential meeting adjournment to secure votes.PHGE
Proxy Filing13 Feb 2026
Next BiomX earnings date
Next BiomX earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage